Prognosis Following Discontinuation of OnabotulinumA Therapy in "Super-responding" Chronic Migraine Patients.

Document Type

Journal Article

Publication Date

9-1-2019

Journal

Headache

Volume

59

Issue

8

Inclusive Pages

1279-1285

DOI

10.1111/head.13630

Comments

Epub 2019 Sep 9

Peer Reviewed

1

Link to Full Text
Find in your library

Share

COinS